Abstract
The European Blood Alliance (EBA) Tissue and Cells annual benchmarking exercise identified that in 2014, the heart valve (HV) discard rate in tissue establishments (TEs) run by EBA members was between 19 and 65%. Given this significant discard rate, a decision was taken to carry out a worldwide data-gathering exercise to assess the processing methodology in different TEs. In collaboration with the Foundation of European Tissue Banks, a questionnaire asking for the details on HV processing was sent to TEs worldwide. Nineteen questionnaires were received back from 15 European TEs and 4 non-European TEs. The data provided confirmed a significant discard rate of HVs with 43–50% of aortic valves and 20–32% of pulmonary valves being discarded in 2015. The causes of HV discard varied, with microbiology contamination, anatomical and medical reasons being the main causes. This data-gathering exercise highlighted significant variations in practice in different TEs including how donor suitability is assessed, critical timings for heart retrieval and processing, heart rinsing, HV decontamination protocols and methods of microbiological testing. To reduce the discard rates, there are several aspects of HV banking that could be validated and standardised. Here, we report the findings of this data-gathering exercise. We consider this a first step that will help lead to standardising HV banking.
Similar content being viewed by others
References
Solari S, Mastrobuoni S, De Kerchove L, Navarra E, Astarci P, Noirhomme P, Poncelet A, Jashari R, Rubay J, El Khoury G (2016) Over 20 years experience with aortic homograft in aortic valve replacement during acute infective endocarditis. Eur J Cardiothorac Surg 50(6):1158–1164
Burtonboy G, Delloye C (1996) Polymerase chain reaction in cadaveric blood and tissues. Transplant Proc 28(5):2927–2928
Laycock KA, Essary LR, Delaney S, Kuhns MC, Pepose JS (1997) A critical evaluation of hepatitis C testing of cadaveric corneal donors. Cornea 16(2):146–150
Miedouge M, Chatelut M, Mansuy JM, Rostaing L, Malecaze F, Sandres-Saune K, Boudet F, Puel J, Abbal M, Izopet J (2002) Screening of blood from potential organ and cornea donors for viruses. J Med Virol 66(4):571–575
Kovacs CS Jr, Koval CE, van Duin D, de Morais AG, Gonzalez BE, Avery RK, Mawhorter SD, Brizendine KD, Cober ED, Miranda C, Shrestha RK, Teixeira L, Mossad SB (2014) Selecting suitable solid organ transplant donors: reducing the risk of donor-transmitted infections. World J Transplant 4(2):43–56
Nehring JR, Sheridan MF, Funk WF, Alderson GL (1971) Studies in postmortem bacteriology. I. Necropsy sterility in three patients as long as thirty-five days postmortem. Am J Clin Pathol 55(1):12–16
Riedel S (2014) The value of postmortem microbiology cultures. J Clin Microbiol 52(4):1028–1033
Lobmaier IV, Vege A, Gaustad P, Rognum TO (2009) Bacteriological investigation--significance of time lapse after death. Eur J Clin Microbiol Infect Dis 28(10):1191–1198
Saegeman V, Verhaegen J, Lismont D, Verduyckt B, De Rijdt T, Ectors N (2009) Influence of postmortem time on the outcome of blood cultures among cadaveric tissue donors. Eur J Clin Microbiol Infect Dis 28(2):161–168
Perry J 2010 “Chapter 3 - Culture Media,” in Medical microbiology. Ford M, Ed.
Brubaker S, Lotherington K, Zhao J, Hamilton B, Rockl G, Duong A, Garibaldi A, Simunovic N, Alsop D, Dao D, Bessemer R, Ayeni OR, Bioburden Steering Committee and Tissue Recovery Working Group (2016) Tissue recovery practices and bioburden: a systematic review. Cell Tissue Bank 17(4):561–571
Jashari R, Tabaku M, Van Hoeck B, Cochez C, Callant M, Vanderkelen A (2007) Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions. Cell Tissue Bank 8(4):247–255
de By TMMH, McDonald C, Sussner S, Davies J, Heng WL, Jashari R, Bogers AJJC, Petit P (2017) Validation of microbiological testing in cardiovascular tissue banks: results of a quality round trial. Eur J Cardiothorac Surg 52(5):895–900
Heng WL, Albrecht H, Chiappini P, Lim YP, Manning L (2013) International heart valve bank survey: a review of processing practices and activity outcomes. J Transp Secur 2013:163150
M. Germain, D. M. Strong, G. Dowling, J. Mohr, A. Duong, A. Garibaldi, N. Simunovic, O. R. Ayeni and Bioburden Steering Committee and Cardiac Tissue Working group, “Disinfection of human cardiac valve allografts in tissue banking: systematic review report,” Cell Tissue Bank., vol. 17, (4), pp. 593–601, 2016
Eastlund T and Winters MK 2010 “Testing the tissue and the environment,” in, Galea G, Ed.
Buzzi M, Guarino A, Gatto C, Manara S, Dainese L, Polvani G, Tothova JD (2014) Residual antibiotics in decontaminated human cardiovascular tissues intended for transplantation and risk of falsely negative microbiological analyses. PLoS One 9(11):e112679
Jashari R, Goffin Y, Vanderkelen A, Van Hoeck B, du Verger A, Fan Y, Holovska V, Brahy O (2010) European homograft bank: twenty years of cardiovascular tissue banking and collaboration with transplant coordination in Europe. Transplant Proc 42(1):183–189
Warwick RM, Magee JG, Leeming JP, Graham JC, Hannan MM, Chadwick M, Crook DW, Yearsley CP, Rayner A, Parker R (2008) Mycobacteria and allograft heart valve banking: an international survey. J Hosp Infect 68(3):255–261
Acknowledgments
We would like to thank all participating TEs for providing the information for this benchmarking exercise—in alphabetical order:
Allograft Heart Valve Bank, Poland
Banco de Tecidos do Instituto Português do Sangue e da Transplantação
Banco de Tejidos de Cordoba
Banque de Tissus, Paris
Barcelona Tissue Establishment
Birmingham Heart Valve Bank
Bloemfontein Homograft Bank, South Africa
Cardiovascular Tissue Establishment of Milan
Croatian Tissue and Cell Bank
Etablissement Française du Sang, Banque de Tissus et Cellules, Bordeaux
Etablissement Française du Sang, Banque de Tissus et Cellules, Lyon
European Homograft Bank, Brussels
Hema Quebec Tissue Establishment, Canada
NHS Blood and Transplant, Tissue and Eye Services, England
Oxford Heart Valve Bank
Scottish National Blood Transfusion Service, Tissue, Cells and Advanced Therapeutics
Thai Red Cross Organ Donation Centre
Tissue Establishment Lund, Sweden
Transplant Tissue Centre, Singapore
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
We can confirm that this work has been carried out in compliance with Ethical Standards. There is no conflict of interest for any of the authors. Ethical approval was not required. Informed consent is not relevant for this work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zahra, S., Galea, G., Jashari, R. et al. Significant variation in heart valve banking practice. Eur J Clin Microbiol Infect Dis 38, 1491–1498 (2019). https://doi.org/10.1007/s10096-019-03577-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03577-0